- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 22, 2025 | 132.1M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.91B |
| Long Term Debt | Q1 2025 · Mar 31, 2024 | $3.33B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q1 2025 · Mar 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $559.7M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $292.4M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $8.12B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $7.49B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.24B |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $696.2M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $8.96B |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $6.39B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.27B |
| Current Assets | Q1 2025 · Mar 31, 2024 | $1.91B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.1B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $13.91B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 133.1M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $18.8M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $62M |
| Capex | Q1 2025 · Mar 31, 2024 | $152.8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $173.4M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.77 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.78 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $129.7M |
| Net Income | Q1 2025 · Mar 31, 2024 | $102.7M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $172.9M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $304.9M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.55B |